These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15334604)

  • 1. Proteomic analysis of phosphotyrosyl proteins in the rat brain: effect of butorphanol dependence.
    Kim SY; Chudapongse N; Lee SM; Levin MC; Oh JT; Park HJ; Ho IK
    J Neurosci Res; 2004 Sep; 77(6):867-77. PubMed ID: 15334604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains.
    Kim SY; Chudapongse N; Lee SM; Levin MC; Oh JT; Park HJ; Ho IK
    Brain Res Mol Brain Res; 2005 Jan; 133(1):58-70. PubMed ID: 15661365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
    Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
    Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression.
    Tanaka S; Fan LW; Tien LT; Park Y; Liu-Chen LY; Rockhold RW; Ho IK
    J Neurosci Res; 2005 Oct; 82(2):255-63. PubMed ID: 16130146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
    Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
    Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butorphanol dependence and withdrawal decrease hippocampal kappa 2-opioid receptor binding.
    Fan LW; Tanaka S; Park Y; Sasaki K; Ma T; Tien LT; Rockhold RW; Ho IK
    Brain Res; 2002 Dec; 958(2):277-90. PubMed ID: 12470863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
    Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
    Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-nitroindazole, nitric oxide synthase inhibitor, attenuates physical dependence on butorphanol in rat.
    Tian YH; Lee KW; You IJ; Lee SY; Jang CG
    Synapse; 2008 Aug; 62(8):582-9. PubMed ID: 18512210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S; Ho IK; Yamamoto T
    Brain Res Bull; 2000 Jul; 52(5):363-9. PubMed ID: 10922515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
    Feng Y; Rockhold RW; Ho IK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):932-8. PubMed ID: 9353416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats.
    Tokuyama S; Wakabayashi H; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1996 Jun; 54(2):461-8. PubMed ID: 8743609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol.
    Fan LW; Tien LT; Tanaka S; Sasaki K; Park Y; Ma T; Rockhold RW; Ho IK
    J Neurosci Res; 2003 Jun; 72(6):781-9. PubMed ID: 12774318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine.
    Wongchanapai W; Tsang BK; He Z; Ho IK
    Pharmacol Biochem Behav; 1998 Aug; 60(4):899-907. PubMed ID: 9700974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors.
    Commiskey S; Fan LW; Ho IK; Rockhold RW
    J Pharmacol Sci; 2005 Jun; 98(2):109-16. PubMed ID: 15942128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
    Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK
    J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa-opioid agonist stimulated regional distribution of [(35)S]GTPgammas binding in butorphanol continuously infused rat.
    Park Y; Jang CG; Ho IK; Ko KH
    Brain Res Bull; 2000 May; 52(1):17-20. PubMed ID: 10779697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S; Ho IK
    Psychopharmacology (Berl); 1996 May; 125(2):135-40. PubMed ID: 8783387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The physical dependence liability of butorphanol: a comparative study with morphine.
    Horan P; Ho IK
    Eur J Pharmacol; 1991 Oct; 203(3):387-91. PubMed ID: 1773823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
    Tokuyama S; Feng Y; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1995 Sep; 284(1-2):101-7. PubMed ID: 8549612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.